Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2009
Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogenRognvald N Blance, Andrew H Sims, Elizabeth Anderson, et al.
Stem Cells (Dayton, Ohio)|September 5, 2014
Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapyKathryn E Williams, Nigel J Bundred, Göran Landberg, et al.
International Journal of Molecular Sciences|December 15, 2017
G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging ConceptsErnestina M De Francesco, Federica Sotgia, Robert B Clarke, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2013
Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS)Gillian Farnie, Rachael L Johnson, Kathryn E Williams, et al.
Developmental Biology|December 25, 2004
A putative human breast stem cell population is enriched for steroid receptor-positive cellsRobert B Clarke, Katherine Spence, Elizabeth Anderson, et al.
Oncotarget|March 4, 2014
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activityMatthew P Ablett, Ciara S O'Brien, Andrew H Sims, et al.
Breast Cancer Research : BCR|September 18, 2013
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cellsJagdeep K Singh, Bruno M Simões, Sacha J Howell, et al.
Breast Cancer Research : BCR|March 19, 2013
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signallingHannah Harrison, Bruno M Simões, Lynsey Rogerson, et al.
Cancer Letters|November 28, 2024
Can we utilise the circadian clock to target cancer stem cells?Jia-Wen Lian, Shi-Yang Li, Robert B Clarke, et al.
Pageof 11